Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — Shareholder Meeting (August 2014)
30 slides from Fisher & Paykel Healthcare's shareholder meeting presentation, Aug 20, 2014
Slide 1: Annual Shareholders' Meeting 2014
Annual Shareholders’ Meeting 2014 20 August 2014
Slide 2: Tony Carter - Chairman
Tony Carter - Chairman Fisher & Paykel HEALTHCARE
Slide 3: Your Board
Your Board Tony Michael Roger Lindsay Carter Daniell France Gillanders Geraldine Arthur Donal McBride Morris O’Dwyer
Slide 4: Agenda
Agenda CHAIR’S ADDRESS MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER’S REVIEW FINANCIAL STATEMENTS RESOLUTIONS VOTING GENERAL QUESTIONS
Slide 5: Our Business
Our Business a Oinaas PATIENTS TREATED DURING THE YEAR USING OUR MEDICAL DEVICES 23 COUNTRIES WHERE OUR PRODUCTS WERE SOLD DURING THE YEAR S,0O00+ 1 CE eng EMPLOYEES GLOBALLY 34 COUNTRIES WHERE OUR PEOPLE ARE LOCATED 200+ DISTRIBUTORS WORLDWIDE U S $ Saitions POTENTIAL MARKET SIZE 2,/00+ TOTAL RANGE
Slide 6: Our Opportunity
Our Opportunity • Healthcare costs are increasing at a rapid rate. Total Expenditure on Health (US$/capita) $9,000 Australia $8,000 Canada $7,000 Germany $6,000 Japan $5,000 New Zealand $4,000 Spain $3,000 United Kingdom $2,000 United States $1,000 $0 1980 1990 2000 2010 Source: OECD Health data htt
Slide 7: 2014 Financial Snapshot
2014 Financial Snapshot NZ$ 97.1m 26% NZ$ 623.4m 12.4cps RECORD NET PROFIT GROWTH IN NET PROFIT RECORD OPERATING TOTAL DIVIDEND FOR THE AFTER TAX AFTER TAX REVENUE YEAR FULLY IMPUTED
Slide 8: Dividend
Dividend • We are 40% Gearing (Debt to Debt Plus Equity Ratio)1 approaching our 35% Actual Gearing Forecast Gearing target level of 30% gearing 25% 12.4cps 56% 20% • The Board will give TOTAL DIVIDEND FOR THE PARTICIPATION IN 15% consideration to YEAR FULLY IMPUTED DIVIDEND REINVESTMENT PLAN FOR F
Slide 9: Our Team
Our Team Fisher & Paykel HEALTHCARE
Slide 10: Your Board
Your Board Tony Michael Roger Lindsay Carter Daniell France Gillanders Geraldine Arthur Donal McBride Morris O’Dwyer
Slide 11: Tony Carter - Chairman
Tony Carter - Chairman Fisher & Paykel HEALTHCARE
Slide 12: Michael Daniell – Managing Director & Chief Executive Officer
Michael Daniell – Managing Director & Chief Executive Officer
Slide 13: Continuous Product Improvement
Continuous Product Improvement
Slide 14: Serving More Patients & More Products for Each Patient
Serving More Patients & More Products for Each Patient Invasive Ventilation Adult Noninvasive Ventilation Optiflow Surgical Invasive Ventilation Neonatal T-Piece Resuscitation Optiflow Junior CPAP Therapy
Slide 15: Increase our international presence
Increase our international presence
Slide 16: A Proven Strategy
A Proven Strategy Continuous product improvement Serve more patient groups More products for each patient Increase our international presence
Slide 17: 2014 Financial Highlights
2014 Financial Highlights 12 Months Ended 12 Months Ended % Change 31 March 31 March 2013 2014 (NZ$m) (NZ$m) Operating revenue 556.3 623.4 +12% RAC operating revenue 301.5 336.9 +12% OSA operating revenue 235.8 270.0 +15% Net profit after tax 77.1 97.1 +26%
Slide 18: Constant currency growth
Constant currency growth OPERATING REVENUE OPERATING PROFIT OPERATING REVENUE OPERATING PROFIT NZ$ MILLIONS NZ$ MILLIONS NZ$ MILLIONS NZ$ MILLIONS 623.4 143.5 563.0 556.3 86.5 516.7 496.3 446.7 112.7 59.2 92.8 35.9 12 13 14 12 13 14 12 13 14 12 13 14 Reported Constant Currency
Slide 19: Respiratory and Acute Care (RAC)
Respiratory and Acute Care (RAC)
Slide 20: Breathing device to be trialled in Africa
Breathing device to be trialled in Africa
Slide 21: Obstructive Sleep Apnea (OSA)
Obstructive Sleep Apnea (OSA)
Slide 22: Graham Lowe on OSA
Graham Lowe on OSA Fisher & Paykel
Slide 23: Obstructive Sleep Apnea (OSA)
Obstructive Sleep Apnea (OSA)
Slide 24: Outlook
Outlook First Half Operating Revenue ~NZ$315 million Net Profit after Tax ~NZ$45 million Full Year Expect at NZD:USD exchange rate of ~0.84 for the balance of the year Operating Revenue ~NZ$650 million Net Profit after Tax ~NZ$100 million
Slide 25: Michael Daniell – Managing Director & Chief Executive Officer
Michael Daniell – Managing Director & Chief Executive Officer
Slide 26: Financial Statements
Financial Statements • Opportunity for shareholders to ask any questions specifically on the financial statements, the auditors’ report or the company’s 2014 annual report. • There will be an opportunity to ask any general questions once all items on the agenda have been considered.
Slide 27: Resolutions
Resolutions • Re-election of Directors • Auditor’s Remuneration • Directors’ Remuneration • Issue of Performance Share Rights • Issue of Options
Slide 28: Voting
Voting • In respect of each resolution, please tick the “for”, “against” or “abstain” box. • Once you have completed your voting, please place your vote in a ballot box. • Please raise your hand if you require a pen. • Results will be announced to NZX and ASX as soon as they are available.
Slide 29: Fisher & Paykel Healthcare
Fisher & Paykel HEALTHCARE
Slide 30: Annual Shareholders' Meeting 2014
Annual Shareholders’ Meeting 2014 20 August 2014
Fisher & Paykel Healthcare — Shareholder Meeting (August 2014) on 6ix